Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Biogen
Company Monitoring Page for Biogen
latest headlines for company on cafepharma
Biogen gene therapy for rare eye disease falls short in key clinical trial
MedCity News
Sun, 05/16/21 - 11:26 pm
Tags:
Biogen
,
gene therapy
,
clinical trials
,
X-linked retinitis pigmentosa
,
cotoretigene toliparvovec
Biogen taps Envisagenics’ AI to speed up RNA splicing R&D
Pharmaforum
Fri, 05/14/21 - 10:44 am
Tags:
Biogen
,
RNA
,
drug discovery
,
Envisagenics
,
artificial intelligence
Biogen buys midphase drug to challenge Roche for stroke market
Fierce Biotech
Wed, 05/12/21 - 11:07 am
Tags:
Biogen
,
acute ischemic stroke
,
stroke
,
TMS
Biogen looks to build better gene therapies through latest deal
BioPharma Dive
Tue, 05/11/21 - 11:45 am
Tags:
Biogen
,
gene therapy
,
Capsigen
Drug pricing watchdog joins the chorus of critics on Biogen's aducanumab: What about charging $2,560 per year?
Endpoints
Thu, 05/6/21 - 10:57 am
Tags:
Biogen
,
aducanumab
,
Alzheimer's disease
,
drug pricing
,
ICER
Zolgensma flatlines, but Spinraza isn’t the beneficiary
EP Vantage
Wed, 04/28/21 - 10:27 am
Tags:
SMA
,
Biogen
,
Novartis
,
Roche
,
Spinraza
,
Zolgensma
,
Evrysdi
Following pressure, Biogen to start compassionate use program for ALS drug tofersen
Seeking Alpha
Tue, 04/27/21 - 10:58 am
Tags:
Biogen
,
ALS
,
tofersen
,
compassionate use guidelines
Biogen's Michel Vounatsos takes home $18.7M in pay as the company battles to take aducanumab to market
Endpoints
Tue, 04/27/21 - 10:48 am
Tags:
Biogen
,
Pharma CEOs
,
Michel Vounatsos
,
executive pay
,
aducanumab
Why Biogen's Better-Than-Expected Q1 Results Weren't Good Enough
Motley Fool
Thu, 04/22/21 - 11:09 am
Tags:
Biogen
,
earnings
Biogen’s Alzheimer’s hopeful aducanumab faces ‘less than a coin flip’s chance’ of FDA approval: analysts
Fierce Pharma
Wed, 04/21/21 - 11:29 pm
Tags:
Biogen
,
aducanumab
,
Alzheimer's disease
Biogen Reports New Spinraza Data in SMA
Global Genes
Wed, 04/21/21 - 10:34 am
Tags:
Biogen
,
Spinraza
,
SMA
The next 2 months in biotech and pharma will be busy. Here's what to watch.
BioPharma Dive
Tue, 04/20/21 - 11:16 pm
Tags:
Biogen
,
aducanumab
,
FDA
,
Vertex Pharmaceuticals
,
Sarepta Therapeutics
,
JNJ
,
AstraZeneca
,
vaccines
,
COVID-19
A new market beckons for Alzheimer’s blood tests
EP Vantage
Mon, 04/19/21 - 11:12 am
Tags:
Alzheimer's disease
,
diagnostics
,
donanemab
,
Eli Lilly
,
Biogen
,
Quanterix
Quiet times return for biopharma takeouts
EP Vantage
Wed, 04/14/21 - 09:26 am
Tags:
M&A
,
Alexion
,
Amgen
,
AstraZeneca
,
Biogen
,
Five Prime Therapeutics
,
Gilead Sciences
,
GW Pharma
,
Horizon Therapeutics
,
Immunomedics
,
Jazz Pharmaceutical
,
Kymab
,
Merck
,
Pandion
,
Sanofi
,
Viela Bio
Sage, Biogen's tremor drug hits goal, but 38% of people drop out
Fierce Biotech
Mon, 04/12/21 - 10:36 am
Tags:
SAGE Therapeutics
,
Biogen
,
essential tremor
,
SAGE-324
,
side effects
,
clinical trials
Biogen adds a late-stage prospect to its growing biosimilar business
BioPharma Dive
Thu, 04/8/21 - 07:44 pm
Tags:
Biogen
,
Actemra
,
anti-inflammatories
,
biosimilars
,
COVID-19
FDA grew too close to Biogen during Alzheimer’s drug development, doctors say
Pharmaforum
Thu, 04/1/21 - 10:51 am
Tags:
FDA
,
Biogen
,
drug development
,
aducanumab
,
Alzheimer's disease
FDA advisers reassert case against approval of Biogen's Alzheimer's drug
BioPharma Dive
Wed, 03/31/21 - 10:55 pm
Tags:
Biogen
,
FDA
,
Alzheimer's disease
,
aducanumab
5 FDA approval decisions to watch in the second quarter
BioPharma Dive
Mon, 03/29/21 - 11:16 pm
Tags:
FDA
,
Biogen
,
aducanumab
,
Acadia Pharmaceuticals
,
pimavanserin
,
AstraZeneca
,
vaccines
,
COVID-19
,
Sanofi
,
Avalglucosidase alfa
,
Pfizer
,
pneumococcal disease
Biogen's Aducanumab: A Look at the Drug’s History and Recent Updates
BioSpace
Sat, 03/27/21 - 12:14 pm
Tags:
Biogen
,
Eisai
,
aducanumab
,
Alzheimer's disease
Pages
« first
‹ previous
…
17
18
19
20
21
22
23
24
25
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.